This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 12,268 
3 out of 387 
Years Active: 2021-2025
Title: **Julian Egger: Innovator in Pharmaceutical Chemistry**
Introduction
Julian Egger is a renowned inventor based in Remscheid, Germany, with a focus on pharmaceutical innovations. He holds four patents, showcasing his contributions to the field of medicinal chemistry. His work primarily revolves around developing processes and compounds aimed at treating significant health conditions, particularly cardiopulmonary disorders.
Latest Patents
Among Julian's notable patents is a groundbreaking process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid. This invention emphasizes innovative methods of crystallization, leading to the production of novel crystalline forms beneficial for medical applications. The compound is aimed at being an effective treatment for various pulmonary and cardiovascular diseases, marking a significant step in pharmaceutical advancements.
Career Highlights
Julian's professional journey includes key positions at notable companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His work within these organizations has been pivotal in advancing product development and research in the pharmaceutical sector. The experience gained there has undoubtedly contributed to his prolific patent portfolio.
Collaborations
Throughout his career, Julian has collaborated with esteemed colleagues, including Britta Olenik and Birgit Keil. This teamwork underscores the importance of collaboration in driving innovation and developing new therapeutic strategies in healthcare.
Conclusion
Julian Egger’s contributions to pharmaceutical chemistry are marked by his innovative spirit and dedication to improving healthcare outcomes. His patented processes and compounds represent significant advancements that have the potential to positively impact the treatment of cardiopulmonary ailments. As an inventor, Julian remains a vital part of the ongoing evolution in medical research and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile